Abbott Plans New Formulations of HIV Medicines
July 21st, 2011 | General » Blog »
Singapore, July 18, 2011: Global Pharma company Abbott has announced that it plans to develop two new formulations of its HIV medicines, Kaletra (lopinavir/ritonavir) and Norvir (ritonavir), to offer new formulation options for people living with HIV-1. The company is currently investigating a new powder formulation of Norvir as well as a co-formulation of three HIV medicines — lopinavir, ritonavir and 3TC (lamivudine). http://www.biospectrumasia.com/Content/180711OTH16650.asp?nl=[[forstats]]